Volume of Disease as a Predictor for Clinical Outcomes in Patients With Melanoma Brain Metastases Treated With Stereotactic Radiosurgery and Immune Checkpoint Therapy

Overview of attention for article published in Frontiers in oncology, January 2022

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (67th percentile)
High Attention Score compared to outputs of the same age and source (89th percentile)

So far, Altmetric has seen 9 X posts from 6 X users, with an upper bound of 23,668 followers.

New article: Volume of Disease as a Predictor for Clinical Outcomes in Patients With Melanoma Brain Metastases Treated With Stereotactic Radiosurgery and Immune Checkpoint Therapy https://t.co/dadc5BHnyn #melanoma #oncology https://t.co/g63HMPA6AR

RT @FrontOncology: 📣Volume of Disease as a Predictor for Clinical Outcomes in Patients With Melanoma Brain Metastases Treated With Stereota…

RT @DrWalterJean: Thank you for the collaborative effort @SbrtSean, @MGUHNeurosurg @LVHNeuroscience

RT @DrWalterJean: Thank you for the collaborative effort @SbrtSean, @MGUHNeurosurg @LVHNeuroscience

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 5 additional X posts.